CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Takeda Pharmaceuticals USA Inc. v. Par Pharmaceutical Companies Inc.

1:13-cv-01524

Overview

Case Number 1:13-cv-01524
Filing Date 2013-08-30
Status Terminated
Termination Date 2016-01-12
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Par Pharmaceutical Inc. Operating Company

Represented By

7 Attorneys Listed

Bradford C. Frese

Email: bradford.frese@afslaw.com

Aziz Burgy

Email: aburgy@axinn.com

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Janine A. Carlan

Email: janine.carlan@afslaw.com

Richard J. Berman

Email: Richard.Berman@afslaw.com

Rhiannon I. D'Agostin

Email: rdagostin@polsinelli.com

Par Pharmaceutical Companies Inc. Operating Company

Represented By

3 Attorneys Listed

Stephen Yang

Email: syang@steptoe.com

Katharine Lester Mowery

Richards, Layton & Finger, PA

Tel: +1 (302) 651-7623

Richards, Layton & Finger, PA, One Rodney Square

Steven J. Fineman

Richards, Layton & Finger, PA

Tel: +1 (302) 658-6541

Richards, Layton & Finger, PA, One Rodney Square

Counter Defendant

Takeda Pharmaceuticals USA Inc. Operating Company

Represented By

10 Attorneys Listed

Heather E. Takahashi

Email: heather.takahashi@mto.com

Hannah Dubina

Email: hannah.dubina@mto.com

Elizabeth A. Laughton

Email: elizabeth.laughton@mto.com

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Jeffrey I. Weinberger

Email: jeffrey.weinberger@mto.com

Tryn T. Stimart

Email: tstimart@gibbonslaw.com

Daniel Marcus Attaway

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4365

1313 North Market Street, Suite 1200

Dana Kathryn Severance

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4329
Fax: +1 (302) 661-7710

1313 North Market Street, Suite 1200

Eric K. Chiu

Email: eric.chiu@mto.com

Amy L. Greywitt

Email: amy.greywitt@mto.com

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 4 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 5 proceedings
🏛️
USPTO PTAB Trials Counterparts in force
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (4): 🇺🇸 US
Parallel Proceedings Across Jurisdictions (5 found):
U.S. Courts: 5
U.S. District Court 2023-11-06
1:23-cv-01264

Takeda Pharmaceuticals U.S.A., Inc. v. Scilex Pharmaceuticals Inc.

U.S. Family Sibling (["US7619004", "US7820681", "US7964648", "US8093297", "US8097655", "US8440722"])
Status: DED
U.S. District Court 2019-12-02
1:19-cv-02216

Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-10-24
1:16-cv-00987

Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2014-02-27
1:14-cv-00268

Takeda Pharmaceuticals USA Inc. v. Watson Laboratories Inc.

Asserted Patent
Status: DED
U.S. District Court 2012-04-04
1:12-cv-00419

Takeda Pharmaceuticals U.S.A. Inc. v. Par Pharmaceutical Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

17 Patents

There are 17 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7906519
Methods for concomitant administration of colchicine and a second active agent
Filed: 2010-08-18
Issued: 2011-03-15
Active (3.7 yrs remaining)
Expires: 2030-08-18
US7935731
Methods for concomitant administration of colchicine and macrolide antibiotics
Filed: 2010-05-25
Issued: 2011-05-03
Active (3.5 yrs remaining)
Expires: 2030-05-25
US8093298
Methods for concomitant administration of colchicine and macrolide antibiotics
Filed: 2011-05-18
Issued: 2012-01-10
Active (4.5 yrs remaining)
Expires: 2031-05-18
US8093297
Methods for concomitant administration of colchicine and a second active agent
Filed: 2011-04-22
Issued: 2012-01-10
Active (4.4 yrs remaining)
Expires: 2031-04-22
US7964648
Methods for concomitant administration of colchicine and a second active agent
Filed: 2010-01-15
Issued: 2011-06-21
Active (3.2 yrs remaining)
Expires: 2030-01-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

51

Dispositive

2

Granted

2

Denied

0

Pending / Review

38

Motions by Category

Procedural / Extension Motion 24 Claim Construction / Markman Filing 23 Motion for Summary Judgment (Infringement) 2 Motion to Stay 2

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Infringement) Pending
Letter to The Honorable Sue L. Robinson from Katherine C. Lester regarding Par and Watson's request to submit a Motion for Partial Summary Judgment of Non Infri...
Entry #158 • 2015-02-19 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
Letter to The Honorable Sue L. Robinson from Katherine C. Lester regarding Par and Watson's request to submit a Motion for Partial Summary Judgment of Non Infri...
Entry #158 • 2015-02-19 Document →
Motion to Stay Pending
SO ORDERED, re 238 Joint MOTION to Stay Action Pending Regulatory Review of Settlement filed by Takeda Pharmaceuticals USA Inc., Case stayed. Signed by Judge Su...
Entry #— • 2015-11-30
Motion to Stay Pending / Under Review
Joint MOTION to Stay Action Pending Regulatory Review of Settlement - filed by Takeda Pharmaceuticals USA Inc.. (Bourke, Mary) (Entered: 11/24/2015)
Entry #238 • 2015-11-24 Document →
Claim Construction / Markman Filing Pending
MEMORANDUM ORDER re: claim construction. Signed by Judge Sue L. Robinson on 6/1/2015. Associated Cases: 1:13-cv-01524-SLR, 1:13-cv-01729-SLR, 1:14-cv-00268-SLR(...
Entry #196 • 2015-06-01 Document →
Claim Construction / Markman Filing Pending / Under Review
MEMORANDUM ORDER re: claim construction. Signed by Judge Sue L. Robinson on 6/1/2015. Associated Cases: 1:13-cv-01524-SLR, 1:13-cv-01729-SLR, 1:14-cv-00268-SLR(...
Entry #196 • 2015-06-01 Document →

Docket Entries

(361 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed against Par Pharmaceutical Companies Inc., Par Pharmaceutical Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1359672.) - filed by Takeda Pharmaceuticals USA Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Civil Cover Sheet)(dmp, ) (Entered: 09/03/2013)

Entry #1 • 2013-08-30
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 09/03/2013)

Entry #2 • 2013-08-30
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 07/22/2013. Date of Expiration of Patent: 08/18/2030 - US 7,906,519, 5/25/3020 - US 7,935,731, 5/18/2031 - US 8,093,298, 01/15/2030 - US 7,964,648, 04/22/2031 - US 8,093,297.Thirty Month Stay Deadline: 1/22/2016. (dmp, ) Modified on 9/3/2013 (dmp, ). (Entered: 09/03/2013)

Entry #3 • 2013-08-30
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,906,519; US 7,935,731; US 8,093,298; US 8,093,297; US 7,964,648;. (dmp, ) (Entered: 09/03/2013)

Entry #4 • 2013-08-30
1

Disclosure Statement pursuant to Rule 7.1 filed by Takeda Pharmaceuticals USA Inc. identifying Corporate Parent Takeda American Holdings Inc., Other Affiliate Takeda Pharmaceutical Company Limited for Takeda Pharmaceuticals USA Inc.. (dmp, ) (Entered: 09/03/2013)

Entry #5 • 2013-08-30
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc